Norion Cancer Immunotherapy
SHORT CODE
NCI
MODEL
Continuous publication
STATUS
In preparation - editorial board being constituted
Aims and scope
Original research and reviews in cancer immunotherapy. Norion Cancer Immunotherapy publishes continuously: accepted articles appear the day of acceptance, each with its own article number in the year's rolling volume. Every submission is peer reviewed, and every decision rests with the journal's editors.